Free Trial

Brainstorm Cell Therapeutics (BCLI) Earnings Date, Estimates & Call Transcripts

Brainstorm Cell Therapeutics logo
$0.91 -0.01 (-0.65%)
As of 10:36 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Brainstorm Cell Therapeutics Earnings Summary

Upcoming Q3
Earnings Date
May. 13Before Market OpensEstimated
Consensus EPS
(Aug. 14)
-$0.60
Actual EPS
(Aug. 14)
-$0.60

Brainstorm Cell Therapeutics announced Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.60, which met the consensus estimate of -$0.60. With a trailing EPS of -$3.66, Brainstorm Cell Therapeutics' earnings are expected to grow next year, from ($3.01) to ($1.60) per share.

Q2 2024 Earnings Resources

BCLI Upcoming Earnings

Brainstorm Cell Therapeutics' Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Brainstorm Cell Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Brainstorm Cell Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BCLI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Brainstorm Cell Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($3.01) EPS
Next Year EPS Consensus Estimate
($1.60) EPS

Brainstorm Cell Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2025
(Estimated)
-------
8/14/2024Q2 2024-$0.60-$0.60--$0.04--
5/14/2024Q1 2024-$1.05-$0.75+$0.30-$0.05--
4/1/2024Q4 2023-$2.25-$1.65+$0.60-$0.11--
11/14/2023Q3 2023-$2.10-$2.10--$0.25--
8/14/2023Q2 2023-$2.25-$4.05 -$1.80-$0.27--
5/15/2023Q1 2023-$2.40-$2.10+$0.30-$0.14--

Brainstorm Cell Therapeutics Earnings - Frequently Asked Questions

Brainstorm Cell Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on BCLI's earnings history.

In the previous quarter, Brainstorm Cell Therapeutics (NASDAQ:BCLI) reported ($0.60) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.60). Learn more on analysts' earnings estimate vs. BCLI's actual earnings.

The conference call for Brainstorm Cell Therapeutics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Brainstorm Cell Therapeutics's latest earnings report can be read online.
Read Transcript

Brainstorm Cell Therapeutics (NASDAQ:BCLI) has a recorded net income of -$17.19 million. BCLI has generated -$3.66 earnings per share over the last four quarters.

Brainstorm Cell Therapeutics's earnings are expected to grow from ($3.01) per share to ($1.60) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BCLI) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners